Lv1
80 积分 2023-04-11 加入
Meta‐analysis: Efficacy and safety of fibroblast growth factor 21 analogues for the treatment of non‐alcoholic steatohepatitis and non‐alcoholic steatohepatitis‐related fibrosis
22小时前
已完结
Efficacy and safety of FGF21 analogues for metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis
23小时前
求助中
Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
7天前
已完结
Safety and Efficacy of Efruxifermin in Combination With a GLP-1 Receptor Agonist in Patients With NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study
10天前
已完结
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
10天前
已完结
The art and science of drug titration
15天前
已完结
Smoking and tardive dyskinesia in male patients with chronic schizophrenia
1个月前
已完结
Risk factors for tardive dyskinesia in adults with intellectual disability, comorbid psychopathology, and long-term psychotropic use
1个月前
已完结
Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions
1个月前
已完结
Safety and effectiveness of lurasidone for the treatment of schizophrenia in Asian patients: Results of a 26‐week open‐label extension study
6个月前
已关闭
皖公网安备34019202002308
